MedPath

SYSMEX CORPORATION

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)
No trials found

News

Sysmex America Secures FDA Clearance for CN-6000 Automated Blood Coagulation Analyzer

Sysmex America received FDA clearance for the CN-6000™ Automated Blood Coagulation Analyzer, enabling high-throughput hemostasis testing for bleeding and clotting disorders.

Sysmex Inostics' RAS-RAF-SEQ Assay Gains New York Approval for Clinical Trial Use

Sysmex Inostics' RAS-RAF-SEQ assay, a liquid biopsy test, has been approved by the New York State Department of Health for clinical trial use.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.